Reata Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RETA Reata Pharmaceuticals Inc
MNTX Manitex International Inc
ACMR ACM Research Inc
DEA Easterly Government Properties Inc
NBSTU Newbury Street Acquisition Corp
UPS United Parcel Service Inc
BOLT Bolt Biotherapeutics Inc
EIX Edison International
EM Smart Share Global Ltd
WTW Willis Towers Watson PLC
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on identifying, developing, and commercializing therapies. The Company is also focused on providing small-molecule therapeutics with mechanisms of action for the treatment of severe, life-threatening diseases with therapies. The Company's lead programs are in rare forms of chronic kidney disease and rare neurological disease. The Company’s Bardoxolone methyl and omaveloxolone products are in development for the treatment of several forms of chronic kidney disease and a severe neurologic disorder called Friedreich’s ataxia, respectively. The Company’s Technologies include Nrf2 Activators and HSP90 Modulators. Nrf2 is a transcription factor that promotes the resolution of inflammation by restoring mitochondrial function, reducing oxidative stress, and inhibiting pro-inflammatory signaling. HSP90 Modulators developing a class of molecules that target pathways involved in the cellular stress response.

Closing Price
$24.90
Day's Change
0.78 (3.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.05
Day's Low
23.08
Volume
(Above Average)
Volume:
761,885

10-day average volume:
668,359
761,885
  • Prev Close
    24.12
  • Today's Open
    24.38
  • Day's Range
    23.08-25.05
  • Avg Vol (10-day)
    668.4K
  • Last (time)
    4:00p ET 01/28/22
  • Last (size)
    493
  • 52-Wk Range
    23.08 - 153.41
    LowHigh
  • (06/29/21 - 01/28/22)
    7.89%
  • 99.5%
  • Market Cap
    906.2M
  • Shares Outstanding
    36.4M
  • -7.74
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 84.08
  • (% of float 01/15/22)
    12.97

Latest News

January 28, 2022
9:00 pm ET
Globe Newswire
5:29 pm ET
Newsfile
3:46 pm ET
Accesswire
2:48 pm ET
Newsfile
1:47 pm ET
PR Newswire
1:30 pm ET
Accesswire
12:15 pm ET
Newsfile
11:51 am ET
Accesswire
11:01 am ET
Accesswire
9:16 am ET
Accesswire
January 27, 2022
6:35 pm ET
Accesswire
6:10 pm ET
PR Newswire
1:57 pm ET
PR Newswire
1:45 pm ET
Accesswire
1:13 pm ET
Accesswire
10:11 am ET
Accesswire
9:45 am ET
Accesswire
9:15 am ET
Accesswire
6:00 am ET
Accesswire
January 26, 2022
7:24 pm ET
Newsfile
6:37 pm ET
Accesswire
5:31 pm ET
PR Newswire
4:01 pm ET
Accesswire
1:22 pm ET
Newsfile
9:35 am ET
Accesswire
8:45 am ET
Accesswire
January 25, 2022
8:50 pm ET
Newsfile
7:22 pm ET
Newsfile
6:45 pm ET
Newsfile
5:19 pm ET
Globe Newswire
4:55 pm ET
Accesswire
4:45 pm ET
Accesswire
2:46 pm ET
Newsfile
1:47 pm ET
Accesswire
1:25 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.